Medicine Research

The Montreal Neurological Institute and Hospital (The Neuro) is home to Canada’s first multiple sclerosis (MS) clinic, and MS research and treatment has been a major focus at The Neuro for many years. The MS clinic employs a highly specialized staff who have access to the latest research data and methods of treatment. It is a clinic where innovation and progress are paramount.

Classified as: Multiple Sclerosis, MNI; medicine research; faculty of medicine
Published on: 1 May 2017

Brain diseases and disorders are the leading cause of disability, directly affecting one in three Canadians as well as millions of family members, friends, colleagues and caregivers. The Government of Canada recognizes the significant impact on the health of Canadians, and supports Canadian research on the brain and related diseases and disorders

Classified as: autism, Alan Evans, brain imaging, Sylvain Baillet, Brain Canada, McConnell Brain Imaging Centre, Canada Brain Research Fund
Published on: 27 Apr 2017

The ability to remember sounds, and manipulate them in our minds, is incredibly important to our daily lives — without it we would not be able to understand a sentence, or do simple arithmetic. New research is shedding light on how sound memory works in the brain, and is even demonstrating a means to improve it.

Classified as: faculty of medicine, memory, External, Montreal Neurological Institute and Hospital (The Neuro)
Published on: 28 Mar 2017

Discovery expands our understanding of how we remember sound

The ability to remember sounds, and manipulate them in our minds, is incredibly important to our daily lives — without it we would not be able to understand a sentence, or do simple arithmetic. New research is shedding light on how sound memory works in the brain, and is even demonstrating a means to improve it.

Classified as: Montreal Neurological Institute, Neurocognition, Neuroimaging and Neuroinformatics
Published on: 27 Mar 2017

Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas – the most common and aggressive brain tumors – are known to recur and progress within short times from the diagnosis. Patients diagnosed with this type of cancer, and who undergo current standard treatment, have a median survival of 16 months.

Classified as: health and lifestyle, Montreal Neurological Institute and Hospital (The Neuro), Research Institute of the McGill University Health Centre (RI-MUHC), Gerald Bronfman Department of Oncology, brain cancer, Department of Neurology & Neurosurgery
Published on: 23 Mar 2017

Montreal, Quebec and Vancouver, British Columbia – Working together to accelerate research into neurological diseases, three leading players in Canada’s health sciences sector are joining forces in a unique multi-million dollar partnership to create a novel drug development platform that will help advance new therapeutics for some of the most debilitating conditions such as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, and Parkinson’s disease.

Classified as: Parkinson's, Merck, drug development, CDRD
Published on: 16 Mar 2017

Discovery could be key to treating brain and spinal cord injury

A foray into plant biology led one researcher to discover that a natural molecule can repair axons, the thread-like projections that carry electrical signals between cells. Axonal damage is the major culprit underlying disability in conditions such as spinal cord injury and stroke.

Classified as: MNI, Neuro, Neurology, stroke, spinal cord injury, axon repair, 14-3-3, Fusicoccin-A
Published on: 8 Mar 2017

Research and clinical care complement each other at The Neuro

February 28th was Rare Diseases Day, an opportunity to recognize a class of disease that is often overlooked. In the past five years, the Montreal Neurological Institute and Hospital (The Neuro) has made the study and treatment of rare diseases a major priority, hiring new specialists and support staff and coordinating activity under a new research group.

Classified as: genetics, Rare disases, Bernard Brais, Eric Shoubridge, ataxia
Published on: 28 Feb 2017

A new mouse model with a working immune system could be used in laboratory research to improve understanding of Zika virus infection and aid development of new treatments, according to a study published in PLOS Pathogens.

Classified as: faculty of medicine, virus, science and technology, zika, Department of Microbiology and Immunology, martin richer, selena sagan, plos pathogens
Published on: 23 Feb 2017

CQDM and Brain Canada join forces again in the funding of two new research projects to address unmet needs in brain research

CQDM and Brain Canada are proud to announce the funding of two new multi-disciplinary and multi-institutional research projects under the second edition of their Focus on Brain strategic initiative. The partners will award a total of $3M to two research teams to develop cutting-edge tools, technologies and platforms designed to accelerate the discovery of new drugs for brain and nervous system disorders.

Classified as: Parkinson's, Ted Fon, ALS, Brain Canada, Canada Brain Research Fund, CQDM, Fon, Edward Fon
Published on: 2 Feb 2017

Project will enhance mental health access for multicultural communities

On Jan. 18, 2017, Bell Let’s Talk announced a donation of $250,000 to McGill University’s Montreal Neurological Institute and Hospital – known as The Neuro – to fund the development of online mental health resources focused on the needs of multicultural communities.

Classified as: Bell, mental health, Bell Let's Talk, Multicultural Mental Health Resource Centre
Published on: 18 Jan 2017

An all-star lineup of experts in the fields of sports and neurology will share a stage on Jan. 27 to discuss concussions, a serious injury that has only recently been getting the attention it deserves.

Classified as: Athletics, brain injury, sport, Concussion, alain ptito, HEADS UP
Published on: 11 Jan 2017

Olivia Oxlade, one of the authors is an epidemiologist at McGill University’s TB centre. http://alturl.com/zzqby 

Classified as: mcgill research; Epidemiology
Published on: 10 Jan 2017

Have you ever met someone who just wasn’t into music? They may have a condition called specific musical anhedonia, which affects three-to-five per cent of the population.

Researchers at the University of Barcelona and the Montreal Neurological Institute and Hospital of McGill University have discovered that people with this condition showed reduced functional connectivity between cortical regions responsible for processing sound and subcortical regions related to reward.

Classified as: neuroscience, Robert Zatorre, specific musical anhedonia, fMRI, University of Barcelona
Published on: 4 Jan 2017

Drug shown to reduce new attacks/symptom progression in some patients

In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.

Classified as: Multiple Sclerosis, Amit Bar-Or, MS, Douglas Arnold, ocrelizumab
Published on: 22 Dec 2016

Pages